ECL
69
5
BF.B
59
5
CA
56
3
CAH
45
-9
AMZN
46
-4
CINF
57
3
AVY
67
6
CB
60
7
A
50
3
ADSK
48
4
CHD
59
3
AVB
20
3
AFL
49
3
BMY
60
2
CMG
50
3
ALL
58
5
CLX
62
3
AA
56
-7
FOXA
35
-7
VIX
52
-5
ECL
69
5
BF.B
59
5
CA
56
3
CAH
45
-9
AMZN
46
-4
CINF
57
3
AVY
67
6
CB
60
7
A
50
3
ADSK
48
4
CHD
59
3
AVB
20
3
AFL
49
3
BMY
60
2
CMG
50
3
ALL
58
5
CLX
62
3
AA
56
-7
FOXA
35
-7
VIX
52
-5
Financhill
Back

Novo Nordisk A/S Stock Predictions

Size matters when it's your portfolio.

Invest now at $0.85/share
Sell
4

NONOF
Novo Nordisk A/S

Last Price:
$47.22
Seasonality Move:
7.77%

7 Day Trial

ALL ACCESS PASS

$ 7

When an AI Platform Gets Pulled by Too Much Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Novo Nordisk A/S Stock Forecast

  • Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 19.4% based on the past 19 years of stock performance.
  • Novo Nordisk A/S has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
  • Is Novo Nordisk A/S Stock Undervalued?
    The current Novo Nordisk A/S [NONOF] share price is $47.22. The Score for NONOF is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk A/S Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 19.4% based on the past 19 years of stock performance.

Novo Nordisk A/S Stock Rating

Sell
4
Novo Nordisk A/S (NONOF) is a Sell

Is Novo Nordisk A/S overpriced?

  • Novo Nordisk A/S has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%

Novo Nordisk A/S Stock Price History

Is NONOF stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
93.83
52-Week Low:
42.01

Prediction Charts

Market Cap:
209.8B
Price in USD:
47.22
Volume:
583.6K
Beta:
0.63

Technical Analysis

SMA50:
53.08
SMA100:
53.59
SMA200:
58.57
52-Wk Change:
-43.52%

Stock Predictions

  • Is Novo Nordisk A/S stock public?
    Yes, Novo Nordisk A/S is a publicly traded company.
  • What is the Novo Nordisk A/S stock quote today?
    The Novo Nordisk A/S stock price is 47.22 USD today.
  • How to buy Novo Nordisk A/S stock online?
    You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-15 58.25 56.17 58.25 55.85
Jan-16 59.75 62.50 62.54 57.50
Jan-20 62.00 60.70 62.11 57.75
Jan-21 60.95 58.10 60.95 57.36
Jan-22 57.00 62.22 62.75 57.00
Jan-23 62.58 63.00 64.75 58.00
Jan-26 64.72 63.20 64.75 58.85
Jan-27 63.00 62.96 64.60 60.42
Jan-28 62.75 58.77 62.75 58.77
Jan-29 58.00 60.01 60.55 57.00
Jan-30 60.09 60.54 60.96 57.72
Feb-2 59.59 59.54 59.94 56.87
Feb-3 58.18 50.00 59.35 49.73
Feb-4 47.50 47.22 49.12 45.15

Novo Nordisk A/S Earnings

Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk A/S Forecast Revenue Growth

Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:

* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.